NEWS & ANNOUNCEMENTS ARCHIVE

HASHTAG SEARCH: #diabetes


BACK TO NEWS
News Story Monday, November 30, 2020

An interesting article was written by Thomas E. Sullivan, M.D. about 3 Ways Technology Can Promote Medication Adherence

An interesting article was written by Thomas E. Sullivan, M.D. about 3 Ways Technology Can Promote Medication Adherence by People with Diabetes. Diabetes is somewhat unique among the diseases of the 21st century, even though it’s been known for thousands of years. Although both Type 1 and Type 2 diabetes are potentially fatal, most patients can live a very long life with proper care, treatment and lifestyle changes. See what he said.
https://bit.ly/39GBVtN

#news#diabetes


News Story Friday, October 23, 2020

Prime Therapeutics researchers studied hypertension, cholesterol and diabetes medications. See the results here.

They found with a population of over 567,000, sample sizes for each drug category and their associated total cost of care savings – from moving someone with low adherence (<50%) to near perfect adherence (99%+) – was as follows:
- RAS: 132,358 in the sample, achieving $2,901 potential savings PPPY
- Statin: 145,038 in the sample, achieving $1,563 potential savings PPPY
- Diabetes: 40,407 in the sample, achieving $3,365 potential savings PPPY
Additionally, the study found lower odds of hospitalizations and emergency room visits were associated with improved drug category adherence.
https://yhoo.it/2ISbiXa

#primetherapeutics#study#hypertension#cholesterol#diabetes


DayaMed Arthur technology is ideal for Payers and Insurance companies that are looking for a solution to reduce their costs.

Our Arthur platform is excellent for using medication adherence to manage chronic illness. Learn how Arthur can give Payers and Insurance companies a competitive advantage.
https://dayamed.com/payers-insurer/

#dayamed#diabetes#chronicillnesses#payers


News Story Monday, April 13, 2020

DayaMed Arthur technology is perfect for insurance companies.

75% of the healthy insured population, support 5% of the insured members who are most chronically ill. These chronic illnesses, primarily diabetes, high cholesterol, and high blood pressure, are preventable and treatable. However, when patient compliance goes down, disease incidents increase, inflating insurance premiums even for those without illness. Arthur's ability to improve a patient's compliance with their therapeutic regimen as well as inform insurance companies about the patient's compliance status not only improves that patient's health but lowers healthcare costs for everyone. Insurance companies now have the ability to base incentives on a patient's compliance with their treatment regimen while implementing a value-based insurance design.

#diabetes#diabetessolutions#insuranceproviders



DAYAMED EXECUTIVE TEAM

SOCIAL MEDIA

Copyright © 2020 Daya Medicals Inc. | PRIVACY | SITEMAP | POWERED BY: CONVEXSTUDIO.CA